CALC.NASDAQCalcimedica, INC

8-K: CalciMedica Changes Auditors, Appoints Moss Adams to Replace Ernst & Young

Sentiment:

8-K Filing


CalciMedica has dismissed Ernst & Young as its independent auditor and engaged Moss Adams for the fiscal year ending December 31, 2024.

Summary

  • CalciMedica's Audit Committee approved the dismissal of Ernst & Young (EY) as their independent registered public accounting firm on April 5, 2024.
  • EY's audit reports for the years ended December 31, 2023 and 2022 did not contain any adverse opinions or disclaimers, and were not qualified or modified.
  • There were no disagreements with EY on accounting principles, financial statement disclosure, or auditing scope, except for a previously disclosed material weakness in internal controls related to convertible promissory notes and warrant liabilities.
  • The company engaged Moss Adams LLP as their new independent registered public accounting firm on April 9, 2024, for the fiscal year ending December 31, 2024.
  • CalciMedica did not consult with Moss Adams on accounting principles or audit opinions prior to their engagement.

Sentiment

Score: 5

Explanation: The change in auditors is a neutral event, but the previously disclosed material weakness in internal controls is a slight concern. The lack of any disagreements with the previous auditor is a positive.

Positives

  • EY's audit reports for the past two years were clean, indicating no major issues with the company's financial statements.
  • The transition to a new auditor was completed quickly, with Moss Adams engaged within days of EY's dismissal.

Negatives

  • The dismissal of EY as the independent auditor could raise concerns among investors.
  • A previously disclosed material weakness in internal controls related to convertible promissory notes and warrant liabilities indicates a potential risk.

Risks

  • The change in auditors could lead to increased scrutiny of the company's financial statements.
  • The previously disclosed material weakness in internal controls could indicate potential issues with financial reporting.

Industry Context

Changes in auditors are not uncommon, but they can sometimes signal underlying issues or a desire for a fresh perspective on financial reporting. It is important to monitor the company's future filings and disclosures for any further developments.

Comparison to Industry Standards

  • The change of auditors is not unusual, but the circumstances surrounding the change should be monitored.
  • Many companies change auditors periodically, but it is important to ensure that the change is not due to disagreements over accounting practices.
  • The fact that EY's reports were clean suggests that the change was not due to any major issues with the company's financial statements.

Stakeholder Impact

  • Shareholders may be concerned about the change in auditors and the previously disclosed material weakness in internal controls.
  • The company's management will need to ensure a smooth transition to the new auditor.

Key Dates

DateDescription
2023-03-31End of the quarter for which a material weakness in internal controls was disclosed in a 10-Q filing.
2023-05-12Date of filing of the 10-Q report disclosing a material weakness in internal controls.
2023-06-30End of the quarter for which a material weakness in internal controls was disclosed in a 10-Q filing.
2023-08-11Date of filing of the 10-Q report disclosing a material weakness in internal controls.
2023-09-30End of the quarter for which a material weakness in internal controls was disclosed in a 10-Q filing.
2023-11-09Date of filing of the 10-Q report disclosing a material weakness in internal controls.
2024-04-05Date of dismissal of Ernst & Young as the independent auditor and approval of Moss Adams as the new auditor.
2024-04-09Date of engagement of Moss Adams as the independent auditor.
2024-04-10Date of the 8-K filing and the letter from Ernst & Young to the SEC.

Keywords

auditor, accounting, financial statements, Ernst & Young, Moss Adams, internal controls, audit, CalciMedica

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.